GNOMvsHELXETF Comparison
Global X Genomics & Biotechnology ETF (GNOM) and Franklin Genomic Advancements ETF (HELX) belong to the same industry segment: BioTech & Genomics. In contrast, HELX's top sector exposures are Healthcare, Non-Energy Materials and Technology. Both GNOM and HELX have the same Total Expense Ratio (TER) of 0.5%. GNOM is up 57.02% year-to-date (YTD) with +$26M in YTD flows. HELX performs worse with 25.31% YTD performance, and +$8M in YTD flows. Run a side-by-side ETF comparison of GNOM and HELX below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
GNOM vs HELX performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | GNOM HELX | +1.76%+2.45% | +32.26%+16.28% | +57.02%+25.31% | +63.61%+32.93% | +104.36%+79.37% | -15.27%-14.67% |
| Flows | GNOM HELX | +$5M+$2M | +$8M+$2M | +$26M+$8M | +$22M+$8M | -$95M+$17M | -$45M+$8M |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | GNOM HELX | +43.63%+27.48% | +32.49%+24.08% | +31.04%+21.93% | +34.22%+23.66% |
| Max drawdown | GNOM HELX | -10.60%-8.93% | -18.16%-17.89% | -43.10%-29.16% | -68.81%-55.27% |
| Max drawdown duration | GNOM HELX | 23d22d | 145d206d | 674d458d | 1819d1821d |
GNOM | HELX | |
Last sale 10/29/2026 at 1:30 PM | $72.54 | $46.01 |
| Previous close 10/28/2026 | $71.51 | $45.47 |
| Consolidated volume 10/28/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
GNOM | HELX | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
GNOM | HELX | |
|---|---|---|
| Last price | $72.54 | $46.01 |
| 1D performance | +1.45% | +1.18% |
| AuM | $113.20 M | $36.38 M |
| E/R | 0.5% | 0.5% |
GNOM | HELX | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | Global X | Franklin Templeton |
| Benchmark | Solactive Genomics Index | - |
| N° of holdings | - | 66 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 5, 2019 | February 25, 2020 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
